National and Kapodistrian University of Athens
Εκτίμηση της μακροπρόθεσμης δράσης των ανταγωνιστών του μετατρεπτικού ενζύμου (καπτοπρίλη) στην κλινική πορεία, την πρόγνωση, τις ηλεκτρολυτικές παραμέτρους του ορού και τα επίπεδα του αγγειοδραστικού εντερικού πεπτιδίου (vasoactive intestinal polypeptide) ασθενών με συμφορητική καρδιακή ανεπάρκεια
Abstract
dc:descriptionCongestive heart failure (CHF) is a common entity with diverse causes, the most important of which are ischemic, hypertensive and dilated cardiomyopathy.Despite the recent improvements in the management of CHF, the annual mortality rate of patients in the endstage is extremely high, ranging from 20% to 50%. Thus there is continuing research to investigate therapeutic modalities that might improve the physical, emotional, hemodynamic and long-term survival rates of these patients.Aim of our study was to investigate the effect of an ACE inhibitor (ca- ptopril) on clinical course and mortality in pts with CHF. Moreover, we try to investigate the effect of captopril on serum Na, K, Mg levels and of VIP plasma levels as these parameters are involved not only in the pathophysiology of this syndrom but also in the long-term prognosis (lethal arrhythmias). Our findings suggest that the addition of captopril in the conventional therapy of CHF is followed by a favorable effect not only on the above plasma parameters but also on clinical course and long-term survival, fingings that has been established in large scale double-blood studies.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2000
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Makris, Thomas
- Μακρής, Θωμάς
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22422